Suppression of Plasmodium MIF-CD74 signaling protects against severe malaria.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
12 2021
Historique:
revised: 23 09 2021
received: 01 07 2021
accepted: 04 10 2021
entrez: 1 11 2021
pubmed: 2 11 2021
medline: 21 12 2021
Statut: ppublish

Résumé

The deadliest complication of infection by Plasmodium parasites, cerebral malaria, accounts for the majority of malarial fatalities. Although our understanding of the cellular and molecular mechanisms underlying the pathology remains incomplete, recent studies support the contribution of systemic and neuroinflammation as the cause of cerebral edema and blood-brain barrier (BBB) dysfunction. All Plasmodium species encode an orthologue of the innate cytokine, Macrophage Migration Inhibitory Factor (MIF), which functions in mammalian biology to regulate innate responses. Plasmodium MIF (PMIF) similarly signals through the host MIF receptor CD74, leading to an enhanced inflammatory response. We investigated the PMIF-CD74 interaction in the onset of experimental cerebral malaria (ECM) and liver stage Plasmodium development by using a combination of CD74 deficient (Cd74

Identifiants

pubmed: 34719814
doi: 10.1096/fj.202101072R
pmc: PMC9022605
mid: NIHMS1788970
doi:

Substances chimiques

Antigens, Differentiation, B-Lymphocyte 0
Histocompatibility Antigens Class II 0
Macrophage Migration-Inhibitory Factors 0
invariant chain 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e21997

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI110452
Pays : United States

Informations de copyright

© 2021 Federation of American Societies for Experimental Biology.

Références

Annu Rev Immunol. 1994;12:259-93
pubmed: 8011283
PLoS Pathog. 2015 Nov 12;11(11):e1005210
pubmed: 26562533
Infect Immun. 2017 Oct 18;85(11):
pubmed: 28874445
Front Immunol. 2019 Nov 01;10:2554
pubmed: 31736970
J Exp Med. 2015 May 4;212(5):825
pubmed: 25941322
Infect Immun. 2015 Jan;83(1):39-47
pubmed: 25312960
Contemp Clin Trials. 2016 Sep;50:166-77
pubmed: 27521810
Nat Commun. 2018 Jun 8;9(1):2223
pubmed: 29884801
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):E2117-26
pubmed: 22778413
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):345-50
pubmed: 11756671
PLoS Pathog. 2014 Jan;10(1):e1003885
pubmed: 24453977
Nucleic Acids Res. 2017 Jan 4;45(D1):D581-D591
pubmed: 27903906
J Immunol. 2017 Dec 15;199(12):4165-4179
pubmed: 29084838
J Med Chem. 2014 Oct 23;57(20):8652-6
pubmed: 25268646
Traffic. 2012 Oct;13(10):1351-63
pubmed: 22780869
J Invest Dermatol. 2015 Nov;135(11):2775-2784
pubmed: 26039541
Arthritis Rheumatol. 2019 Jan;71(1):109-120
pubmed: 30009530
Semin Immunopathol. 2015 May;37(3):221-31
pubmed: 25772948
EMBO Mol Med. 2013 Jul;5(7):984-99
pubmed: 23681698
Infect Immun. 2007 Mar;75(3):1116-28
pubmed: 17158894
Cell Rep. 2014 Jan 16;6(1):196-210
pubmed: 24388751
Nat Med. 2007 May;13(5):587-96
pubmed: 17435771
Immunity. 1995 Sep;3(3):373-83
pubmed: 7553001
Nucleic Acids Res. 2009 Jan;37(Database issue):D539-43
pubmed: 18957442
J Immunol. 2008 Jun 15;180(12):8250-61
pubmed: 18523291
Front Cell Infect Microbiol. 2014 Aug 21;4:104
pubmed: 25191643
J Clin Invest. 2020 Mar 2;130(3):1128-1138
pubmed: 31821175
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7404-7409
pubmed: 29954866
Clin Vaccine Immunol. 2010 Oct;17(10):1524-32
pubmed: 20702656
Infect Immun. 2012 Apr;80(4):1399-407
pubmed: 22252874
J Immunol. 2002 Dec 1;169(11):6369-75
pubmed: 12444144
J Med Chem. 2012 Nov 26;55(22):10148-59
pubmed: 23067344
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11313-8
pubmed: 20534506
Nat Immunol. 2008 Jul;9(7):725-32
pubmed: 18563083
Nat Commun. 2018 Jul 13;9(1):2714
pubmed: 30006528
J Immunol. 2002 Feb 15;168(4):1610-7
pubmed: 11823488
Nat Immunol. 2012 Feb 05;13(3):237-45
pubmed: 22306692
J Exp Med. 2003 Jun 2;197(11):1467-76
pubmed: 12782713
J Infect Dis. 2011 Jan 15;203(2):211-9
pubmed: 21288821
Cell Rep. 2013 Mar 28;3(3):630-7
pubmed: 23478020
PLoS Pathog. 2015 Jun 05;11(6):e1004963
pubmed: 26046849
J Med Chem. 2009 Jan 22;52(2):416-24
pubmed: 19090668
Trends Parasitol. 2011 Dec;27(12):565-74
pubmed: 22015112
Cell Microbiol. 2005 Apr;7(4):603-9
pubmed: 15760460
Mol Microbiol. 2005 Nov;58(3):731-42
pubmed: 16238623

Auteurs

Alvaro Baeza Garcia (A)

Department of Internal Medicine, Yale School of Public Health, New Haven, Connecticut, USA.

Edwin Siu (E)

Department of Internal Medicine, Yale School of Public Health, New Haven, Connecticut, USA.

Xin Du (X)

Department of Internal Medicine, Yale School of Public Health, New Haven, Connecticut, USA.

Lin Leng (L)

Department of Internal Medicine, Yale School of Public Health, New Haven, Connecticut, USA.

Blandine Franke-Fayard (B)

Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.

Chris J Janse (CJ)

Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.

Shanshan W Howland (SW)

Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.

Laurent Rénia (L)

Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.

Elias Lolis (E)

Department of Pharmacology, School of Medicine, Yale University, New Haven, Connecticut, USA.

Richard Bucala (R)

Department of Internal Medicine, Yale School of Public Health, New Haven, Connecticut, USA.
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH